Q4 2016 Holdings
Filed 2017-02-14 | 199 holdings | $1.4M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2017-05-02) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Neurocrine Biosciences(NBIX) | COM | 64125C109 | $128.3K | 3,316,523 | 9.1% |
| Tesaro | COM | 881569107 | $92.5K | 687,993 | 6.6% |
| Amicus Therapeutics(FOLD) | COM | 03152W109 | $86.0K | 17,296,672 | 6.1% |
| Sarepta Therapeutics(SRPT) | COM | 803607100 | $76.0K | 2,769,829 | 5.4% |
| Versartis | COM | 92529L102 | $61.9K | 4,153,685 | 4.4% |
| Retrophin | COM | 761299106 | $50.9K | 2,687,412 | 3.6% |
| Nxstage Medical | COM | 67072V103 | $50.5K | 1,927,989 | 3.6% |
| Xencor(XNCR) | COM | 98401F105 | $47.0K | 1,785,018 | 3.3% |
| Global Blood Therapeutics | COM | 37890U108 | $45.2K | 3,128,978 | 3.2% |
| Eagle Pharmaceuticals(EGRX) | COM | 269796108 | $39.5K | 498,198 | 2.8% |
| Aclaris Therapeutics(ACRS)A | COM | 00461U105 | $34.2K | 1,260,847 | 2.4% |
| Ardelyx(ARDX)A | COM | 039697107 | $26.1K | 1,836,196 | 1.9% |
| Lion Biotechnologies Inc | COM | 53619R102 | $24.8K | 3,567,553 | 1.8% |
| Regenxbio(RGNX) | COM | 75901B107 | $23.8K | 1,282,286 | 1.7% |
| Colucid Pharmaceuticals | COM | 19716T101 | $23.3K | 641,364 | 1.7% |
| LA Jolla Pharmaceutical(LJPC) | COM | 503459604 | $23.1K | 1,319,274 | 1.6% |
| Avexis | COM | 05366U100 | $22.6K | 473,531 | 1.6% |
| DBV Technologies ADR Representing 0.5 | COM | 23306J101 | $21.5K | 610,643 | 1.5% |
| Galapagos ADR Representing(GLPG) | COM | 36315X101 | $20.6K | 304,531 | 1.5% |
| VBI Vaccines(VAC2USD)A | COM | 91822J103 | $20.4K | 6,565,843 | 1.4% |
| Wave Life Sciences(WVE) | COM | Y95308105 | $18.1K | 665,198 | 1.3% |
| ANI Pharmaceuticals(ANIP)A | COM | 00182C103 | $16.2K | 267,100 | 1.2% |
| Acceleron Pharma(XLRN) | COM | 00434H108 | $15.8K | 619,987 | 1.1% |
| Foamix Pharmaceuticals | COM | M46135105 | $14.7K | 1,322,994 | 1.0% |
| Avadel Pharmaceuticals | COM | 05337M104 | $14.4K | 1,388,240 | 1.0% |
| Acelrx Pharmaceuticals(ACRXUSD) | COM | 00444T100 | $14.1K | 5,408,728 | 1.0% |
| Quotient | COM | G73268107 | $13.8K | 2,854,486 | 1.0% |
| Acorda Therapeutics | COM | 00484M106 | $13.5K | 720,000 | 1.0% |
| Zynerba Pharmaceuticals | COM | 98986X109 | $13.1K | 842,128 | 0.9% |
| Kadmon(KDMN) | COM | 48283N106 | $11.8K | 2,209,657 | 0.8% |
| Irhythm Technologies(IRTC) | COM | 450056106 | $10.6K | 352,241 | 0.8% |
| Corbus Pharmaceuticals Holdings Inc(CRBPEUR)A | COM | 21833P103 | $10.6K | 1,250,000 | 0.8% |
| Aldeyra Therapeutics(ALDX)A | COM | 01438T106 | $10.4K | 1,940,458 | 0.7% |
| Cytomx Therapeutics(CTMX)A | COM | 23284F105 | $10.2K | 923,763 | 0.7% |
| Radius Health | COM | 750469207 | $10.0K | 263,872 | 0.7% |
| Dermira(DERMEUR) | COM | 24983L104 | $9.9K | 325,583 | 0.7% |
| Minerva Neurosciences Inc(NERVGBP) | COM | 603380106 | $9.5K | 810,537 | 0.7% |
| Zogenix | COM | 98978L204 | $9.1K | 752,999 | 0.7% |
| ANI Pharmaceuticals Inc 01Dec19 3.0pct | NOTE | 00182CAA1 | $8.7K | $7,500,000 | 0.6% |
| Assembly Biosciences | COM | 045396108 | $8.7K | 714,354 | 0.6% |
| Biocryst Pharmaceuticals(BCRX)A | COM | 09058V103 | $8.4K | 1,330,240 | 0.6% |
| Pfenex | COM | 717071104 | $8.3K | 914,376 | 0.6% |
| Five Prime Therapeutics(FPRX) | COM | 33830X104 | $8.2K | 163,255 | 0.6% |
| Myokardia | COM | 62857M105 | $8.1K | 624,694 | 0.6% |
| Cidara Therapeutics | COM | 171757107 | $8.0K | 773,369 | 0.6% |
| Alder Biopharmaceuticals(ALDR1EUR) | COM | 014339105 | $8.0K | 384,169 | 0.6% |
| Blueprint Medicines(2L9) | COM | 09627Y109 | $7.7K | 273,820 | 0.5% |
| Clovis Oncology(CLVSEUR) | COM | 189464100 | $7.5K | 167,754 | 0.5% |
| Uniqure(QURE) | COM | N90064101 | $7.1K | 1,265,963 | 0.5% |
| Antares Pharma(ATRSEUR) | COM | 036642106 | $6.8K | 2,917,253 | 0.5% |